Keywords: GlaxoSmithKline, Pandemrix, EMA, Prescribing advice, Labeling, Flu vaccine, Narcolepsy

EMA updates Rxing advice for GlaxoSmithKline’s Pandemrix reflecting possible narcolepsy link

Article | 18 April 2011

Print This

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended that the product information for UK ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in